Tanaka, Akane <br/><br/>
Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC/NgaTnd mice.  [electronic resource] 

 -  The Journal of investigative dermatology  Apr 2007 
 - 855-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/sj.jid.5700603  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Animals<br/>B-Lymphocytes--metabolism<br/>Benzamides--administration & dosage<br/>Cell Lineage<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Dermatitis, Atopic--pathology<br/>Down-Regulation<br/>Immunocompetence<br/>Immunoglobulin E--biosynthesis<br/>Immunosuppressive Agents--pharmacology<br/>Keratinocytes--pathology<br/>Male<br/>Mast Cells--drug effects<br/>Mice<br/>Mice, Inbred Strains<br/>NF-kappa B--antagonists & inhibitors<br/>Neurites--drug effects<br/>Ointments<br/>Severity of Illness Index<br/>Skin--drug effects<br/>Spleen<br/>Tacrolimus--pharmacology<br/>Th2 Cells--metabolism<br/>Tumor Necrosis Factor-alpha--metabolism